Chris T Longenecker Selected Research

Chris T Longenecker Research Topics

Disease

20	Inflammation (Inflammations) 01/2020 - 01/2012
13	HIV Infections (HIV Infection) 01/2021 - 06/2009
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2014
7	Atherosclerosis 01/2022 - 10/2013
7	Heart Failure 01/2021 - 06/2014
6	Insulin Resistance 12/2020 - 01/2012
4	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2022 - 03/2016
4	Vascular Diseases (Vascular Disease) 01/2016 - 04/2014
3	Stroke (Strokes) 01/2022 - 01/2019
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2017 - 10/2013
2	Pain (Aches) 01/2022 - 03/2015
2	Hypertension (High Blood Pressure) 10/2021 - 10/2019
2	Rheumatic Fever (Acute Articular Rheumatism) 11/2019 - 03/2015
2	Myocardial Infarction 01/2019 - 11/2017
1	Fatigue 01/2022
1	Fibrosis (Cirrhosis) 01/2021
1	Heart Diseases (Heart Disease) 01/2020
1	Infections 10/2019
1	Hyperlipidemias (Hyperlipidemia) 10/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019
1	Pulmonary Hypertension 01/2019
1	Body Weight (Weight, Body) 01/2018
1	Weight Gain 01/2018
1	Leukocytosis (Pleocytosis) 01/2018
1	Disease Progression 11/2017
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2016
1	Peripheral Arterial Disease 04/2016
1	Muscular Diseases (Myopathy) 01/2016
1	Immune System Diseases (Immune Disorders) 01/2016
1	Myalgia 01/2016
1	Ascites 12/2015
1	Endomyocardial Fibrosis 12/2015
1	Spontaneous Coronary Artery Dissection 06/2015
1	Rheumatoid Arthritis 06/2014
1	Necrosis 01/2013
1	Vitamin D Deficiency 01/2012

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2017 - 10/2014
6	LDL CholesterolIBA 01/2021 - 10/2013
6	CalciumIBA 01/2020 - 04/2014
6	Rosuvastatin Calcium (Crestor)FDA Link 10/2017 - 10/2014
4	oxidized low density lipoproteinIBA 01/2017 - 04/2014
3	LipidsIBA 10/2019 - 10/2013
3	Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link 11/2017 - 03/2015
3	C-Reactive ProteinIBA 10/2016 - 10/2013
3	Cystatin CIBA 06/2015 - 06/2009
2	CarbohydratesIBA 01/2022 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 12/2020 - 01/2017
2	CholesterolIBA 01/2020 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 10/2017
2	HDL CholesterolIBA 10/2019 - 01/2012
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2016 - 01/2013
2	RNA (Ribonucleic Acid)IBA 04/2014 - 01/2012
1	AnticoagulantsIBA 01/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2017
1	Arginine (L-Arginine)FDA Link 11/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2017
1	Insulin (Novolin)FDA Link 10/2017
1	Penicillins (Penicillin)FDA Link 01/2017
1	AutoantibodiesIBA 03/2016
1	Immunoglobulin M (IgM)IBA 03/2016
1	Atorvastatin (Lipitor)FDA Link 02/2016
1	coenzyme Q10 (CoQ10)IBA 01/2016
1	Prednisolone (Predate)FDA LinkGeneric 12/2015
1	pro-brain natriuretic peptide (1-76)IBA 01/2015
1	CreatinineIBA 10/2014
1	Fibrinogen (Factor I)FDA Link 04/2014
1	Lipopolysaccharide ReceptorsIBA 04/2014
1	AdipokinesIBA 05/2013
1	Cell Adhesion MoleculesIBA 01/2013
1	fibrin fragment D (D-dimer)IBA 01/2013
1	InterleukinsIBA 01/2013
1	Cholecalciferol (Vitamin D3)FDA Link 01/2012
1	Vitamin D FDA LinkGeneric 01/2012

Therapy/Procedure

18	Therapeutics 01/2020 - 01/2012
11	Art Therapy 01/2022 - 10/2013
2	Injections 01/2017 - 03/2015
1	Retention in Care 01/2022
1	Length of Stay 11/2019
1	Patient Readmission 10/2019
1	Transcatheter Aortic Valve Replacement 01/2018
1	Duration of Therapy 11/2017
1	Cardiac Rehabilitation 04/2016
1	Cesarean Section (Caesarean Section) 06/2015